Jasveen Sangha, called the “Ketamine Queen,” ran a secret drug network in Hollywood that supplied ketamine to famous people, including actor Matthew Perry. Her home was filled with large amounts of the drug, revealing a hidden world of addiction and danger beneath Hollywood’s glamorous surface. Linked to multiple deaths, Sangha’s story shows how fame and pressure can lead to dark choices. Her arrest sparked a big investigation exposing how some people close to stars helped fuel this deadly cycle. In the end, her rise and fall warn us about the high price of secrets and addiction in the city of dreams.
Jasveen Sangha, known as the “Ketamine Queen,” operated a sophisticated ketamine supply network in Hollywood. Linked to multiple deaths, including actor Matthew Perry’s, she supplied the drug to celebrities, exposing the dark underworld of substance abuse and secrecy in the entertainment industry.
Los Angeles has always embodied a paradox – its sunlit boulevards and iconic skylines symbolize ambition and allure, yet beneath the surface, a darker current pulses. Here, aspiration often collides with excess, leaving tangled stories of fortune, fame, and downfall. Into this landscape stepped Jasveen Sangha, a figure whose social savvy and charisma earned her the nickname “Ketamine Queen.” Her rise and fall offers a rare glimpse into the hidden networks that operate alongside Hollywood’s dazzling red carpets and legendary after-parties.
Sangha, a dual citizen of the US and UK aged 42, became a household name not for her own fame, but by becoming the focal point of a sweeping federal investigation. The spark behind that scrutiny ignited with the death of actor Matthew Perry in October 2023 – a loss that shook the entertainment world and cast a harsh light on the circles moving illicit substances among Hollywood’s elite. Sangha’s home, described by prosecutors as a “drug-selling emporium,” soon became the epicenter of a scandal, exposing an underworld fueled by the demands of status, secrecy, and self-indulgence.
As federal agents converged on Sangha’s Los Angeles address, they unearthed evidence that painted a picture of an operation as sophisticated as it was insidious. Refrigerated vials of ketamine – a substance that began as a 1960s anesthetic but has since carved out a new identity as both antidepressant and party drug – filled her home in quantities that spoke of organization and reach. In private, Sangha navigated the city’s most exclusive circles, her confidence and connections camouflaging the risks beneath her high-profile lifestyle.
The relationship between Hollywood and intoxicants stretches almost as far back as the film industry itself. Early 20th-century icons like Fatty Arbuckle faced notorious scandals, and by the 1970s, stories of wild cocaine parties and prescription pill dependency were so common they became part of the city’s mythos. Jasveen Sangha’s chapter, while shocking, follows a well-trodden path – a testament to the enduring interplay between creative risk-taking and self-destructive temptation that seems woven into the fabric of show business.
For many insiders, ketamine, sometimes referred to as “Special K,” represents both progress and peril. On one hand, it offers hope as a fast-acting treatment for depression and chronic pain, and on the other, it’s the substance of choice for those seeking altered consciousness during long, decadent nights. Sangha recognized ketamine’s conflicted reputation and marketed her services to a clientele that prized privacy and exclusivity. Authorities believe she began running her operation in 2019, customizing the experience for celebrities and wealthy patrons who relied on her silence as much as her supply.
Her story is not just about a single “dealer,” but about a system that perpetuates demand, offering an escape from pressures unique to the entertainment world. Hollywood’s duality – its ability to foster both innovation and destruction – set the stage for Sangha to flourish, until the consequences became impossible to ignore.
Matthew Perry’s death revealed a complicated supply chain that drew in multiple actors. Federal investigators tied Sangha to five criminal charges, including distributing ketamine and causing a death by narcotics. Yet, the blame extended far beyond her. Two medical professionals – a pair of doctors – also pleaded guilty. They issued prescriptions or directly supplied the drug, violating both their legal obligations and the ethics of their profession. Perry’s live-in assistant, who many would expect to be a guardian of his health, instead became complicit in facilitating his drug use, even taking part in the administration of ketamine. Another supplier, working through Sangha, added yet another link in the tragic chain.
Each member of this clandestine circle had their role, their own justification, but together they created an ecosystem that thrived on secrecy and profit. Federal authorities concluded that greed motivated each participant, reducing every exchange to a transaction, regardless of the human cost. The Justice Department’s findings painted a damning picture: those entrusted with healing and care instead contributed to a cycle of dependency and, ultimately, death.
The fallout extended further. Investigators tied Sangha’s ketamine to another fatality – Cody McLaury, who died in August 2019, only hours after purchasing from her. These deaths, far from isolated incidents, revealed the wider dangers lurking behind the city’s most glamorous façade. Each overdose left behind ripples of grief, but the machinery of the underground market carried on, sustained by money, influence, and silent complicity.
Jasveen Sangha meticulously curated her public image. Social media posts featured her at celebrity galas, mingling at events like the Golden Globes and the Oscars. Her feeds projected an aura of effortless belonging in Hollywood’s most exclusive circles – a portrait of success and influence that masked her double life. This careful self-presentation wasn’t just about vanity; it was a strategic move, echoing a long tradition in avant-garde art and society where blurring the boundaries between authenticity and performance becomes its own art form.
Her dual identity – socialite and supplier – mirrored the “fixer” archetype from classic noir films: someone who exists on the periphery, facilitating what others won’t speak of, yet remaining largely invisible. Unlike fictional fixers, however, the consequences Sangha faced were all too real, from courtroom drama to the very real losses endured by her clients and their families.
The allure of the Hollywood dream has always included a dark undercurrent. Writers like F. Scott Fitzgerald and directors like Billy Wilder chronicled the city’s capacity to elevate and destroy in equal measure. Sangha’s story, with its mix of privilege, secrecy, and downfall, fits squarely into this tradition – a modern incarnation of the “beautiful and damned.”
The prosecution of Jasveen Sangha and her associates marks a significant moment in the ongoing conversation about substance abuse in the entertainment industry. Public fascination with celebrity crises is nothing new, but the systems that enable such tragedies rarely receive the same attention. Over the years, high-profile deaths – from John Belushi to River Phoenix – have forced the industry to reflect, though the underlying forces of stress, anxiety, and relentless scrutiny remain as powerful as ever.
Hollywood’s rise-and-fall stories echo broader American themes – reinvention, ambition, and loss. The city’s landscapes – adorned with palm trees and neon – conceal a reality where hope and heartbreak often coexist. Sangha’s downfall reminds us that the red carpet’s glow is often cast atop shadows of private pain, secret arrangements, and, sometimes, irreversible choices.
The double-edged nature of substances like ketamine lies at the heart of this tragedy. The Greek term “pharmakon” captures both cure and curse – a fitting description for drugs that promise relief but can just as easily bring ruin. Sangha’s journey from influential social figure to criminal defendant underscores how quickly Hollywood’s embrace can turn lethal, and how those who supply or facilitate escape are often ensnared by the very forces they sought to control.
As Jasveen Sangha awaits sentencing, her story resonates through Hollywood’s corridors of power and privilege. The repercussions stretch far beyond her personal fate, challenging assumptions about accountability, exploitation, and the price of secrecy in a culture built on both innovation and illusion. For every red-carpet moment, there are hidden negotiations, quiet dependencies, and sometimes fatal consequences.
The city’s unique blend of hope and hazard ensures stories like Sangha’s won’t be the last. Yet, her case stands as a stark reminder: in Hollywood, the brightest ambitions often generate the darkest shadows, and those who navigate these worlds must reckon with the risks as well as the rewards.
By exposing the reality behind the myth, Sangha’s rise and fall offer a cautionary tale about trust, temptation, and the enduring struggle between light and darkness in America’s city of dreams.
Jasveen Sangha is a Hollywood figure who operated an extensive ketamine distribution network, supplying the drug primarily to celebrities. Dubbed the “Ketamine Queen,” she became infamous after her arrest linked to multiple deaths, including that of actor Matthew Perry. Her operation highlighted the hidden drug culture thriving behind Hollywood’s glamorous facade.
Starting around 2019, Sangha built a sophisticated supply chain providing ketamine to high-profile clients in exclusive circles. Her home was described as a “drug-selling emporium,” stocked with refrigerated vials of ketamine. She tailored her services for privacy-conscious celebrities, leveraging her social connections and discretion to maintain secrecy while fueling demand.
The scandal involved multiple participants beyond Sangha. Two doctors pleaded guilty to illegally prescribing or supplying ketamine. Matthew Perry’s live-in assistant was also implicated in facilitating and administering the drug. Another supplier worked through Sangha, creating a complex and deadly supply chain. These actors collectively contributed to a cycle of addiction and tragedy within Hollywood.
Ketamine originated as an anesthetic in the 1960s and has gained recognition as a fast-acting antidepressant and pain reliever. However, it is also used recreationally as “Special K” for its dissociative and hallucinogenic effects. This dual nature makes ketamine both a potential medical breakthrough and a substance of abuse, particularly in environments like Hollywood where altered states and escape are sought after.
Hollywood has a long and complex history with substance abuse, from early scandals involving alcohol and cocaine to prescription drug dependencies. Sangha’s case underscores the persistent pressures faced by entertainers – stress, anxiety, and the demand to maintain image – that can lead to dangerous coping mechanisms. Her story is part of a recurring pattern where fame and privilege intersect with self-destruction.
Sangha’s rise and fall reveal the high cost of secrecy and enabling addiction within Hollywood. The case exposes how greed and complicity among suppliers, medical professionals, and insiders perpetuate deadly drug use. It highlights the need for greater accountability, better support systems for addiction, and a cultural shift away from glamorizing substance abuse in the entertainment world.
South Africa is making big changes to keep a close eye on its top leaders!…
Cape Town is bursting with sports action from December 5th to 7th, 2025! You can…
South African cheesemakers dazzled at the 2025 World Cheese Awards in Switzerland! They won many…
Mozambique and South Africa just held their 4th big meeting, the BiNational Commission, in Maputo.…
South Africa and Mozambique are like old friends, working together to make things better. They…
South Africa's water system is a mess! Almost half of its drinking water isn't safe,…